EA201990301A1 - SUBSTITUTED PYROLYSINE AND THEIR APPLICATION - Google Patents

SUBSTITUTED PYROLYSINE AND THEIR APPLICATION

Info

Publication number
EA201990301A1
EA201990301A1 EA201990301A EA201990301A EA201990301A1 EA 201990301 A1 EA201990301 A1 EA 201990301A1 EA 201990301 A EA201990301 A EA 201990301A EA 201990301 A EA201990301 A EA 201990301A EA 201990301 A1 EA201990301 A1 EA 201990301A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
pyrolysine
application
hbv
hepatitis
Prior art date
Application number
EA201990301A
Other languages
Russian (ru)
Other versions
EA038135B1 (en
Inventor
Цзиньфа Ду
Джошуа А. Каплан
Торстен А. Киршберг
Тецуя Кобаяси
Скотт Э. Лазервит
Рик Эндрю Ли
Джонатан Уильям Медли
Майкл Л. Митчелл
Филип Энтони Морганелли
Хён-Чон Пён
София Л. Шевик
Нил Х. Сквайерс
Уильям Дж. Уоткинс
Original Assignee
Джилид Сайэнс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Джилид Сайэнс, Инк. filed Critical Джилид Сайэнс, Инк.
Priority claimed from PCT/US2017/048565 external-priority patent/WO2018039531A1/en
Publication of EA201990301A1 publication Critical patent/EA201990301A1/en
Publication of EA038135B1 publication Critical patent/EA038135B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A61K31/03—Halogenated hydrocarbons carbocyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящая заявка относится к замещенным конденсированным пирролам формулы I и содержащим их фармацевтическим композициям, которые ингибируют репликацию вируса гепатита B (HBV), а также к способам их получения и применения.This application relates to substituted fused pyrroles of formula I and pharmaceutical compositions containing them that inhibit the replication of hepatitis B virus (HBV), as well as methods for their preparation and use.

EA201990301A 2016-11-01 2017-08-25 Substituted pyrrolizines and use thereof EA038135B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662416020P 2016-11-01 2016-11-01
PCT/US2017/048565 WO2018039531A1 (en) 2016-08-26 2017-08-25 Substituted pyrrolizine compounds and uses thereof

Publications (2)

Publication Number Publication Date
EA201990301A1 true EA201990301A1 (en) 2019-07-31
EA038135B1 EA038135B1 (en) 2021-07-12

Family

ID=67399645

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201990301A EA038135B1 (en) 2016-11-01 2017-08-25 Substituted pyrrolizines and use thereof
EA202190987A EA202190987A1 (en) 2016-11-01 2017-08-25 SUBSTITUTED PYRROLYSINS AND THEIR APPLICATION

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA202190987A EA202190987A1 (en) 2016-11-01 2017-08-25 SUBSTITUTED PYRROLYSINS AND THEIR APPLICATION

Country Status (1)

Country Link
EA (2) EA038135B1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3357906B1 (en) * 2013-07-25 2019-12-04 Janssen Sciences Ireland Unlimited Company Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b

Also Published As

Publication number Publication date
EA202190987A1 (en) 2021-11-30
EA038135B1 (en) 2021-07-12

Similar Documents

Publication Publication Date Title
PH12019500393A1 (en) Substituted pyrrolizine compounds and uses thereof
EA201890200A1 (en) DERIVATIVES OF CYCLIZED SULFAMOILARILAMIDE AND THEIR APPLICATION AS A MEDICINE PREPARATION FOR THE TREATMENT OF HEPATITIS B
EA201990495A1 (en) BIARY COMPOUNDS APPLICABLE AS IMMUNOMODULATORS
EA202091898A1 (en) ANTIBODIES THAT NEUTRALIZE THE HUMAN IMMUNODEFICIENCY VIRUS
EA201691579A1 (en) DERIVATIVES OF SULFAMOILPYRROLAMIDE AND THEIR APPLICATION AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201891876A1 (en) TETRACYCLIC PYRIDONE COMPOUNDS AS ANTI-VIRUS MEANS
EA201792354A1 (en) BATCHOLEIC ACID COMPOSITIONS AND METHODS OF APPLICATION
EA201690277A1 (en) DERIVATIVES OF GLYOXAMID FAMILIATED PYRROLAMIDE AND THEIR APPLICATION AS A MEDICINAL MEANS TO TREAT HEPATITIS B
EA201691261A1 (en) NEW DIHYDROCHINOLYSINES FOR THE TREATMENT AND PREVENTION OF INFECTION CAUSED BY THE HEPATITIS B VIRUS
GEP20227374B (en) Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv)
EA201690760A1 (en) DERIVATIVES OF CARBOXAMIDE AND THEIR USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
EA201790781A2 (en) ANTI-VIRUS COMPOUNDS
EA201790389A1 (en) PYRROPYRIMIDINE COMPOUNDS USED AS AN AGLIST TLR7
EA201591524A1 (en) DERIVATIVES 2-AMINOPYRIMIDINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201591586A1 (en) SULFAMOIL-ARYLAMIDE AND THEIR APPLICATION AS A MEDICINE DRUG FOR THE TREATMENT OF HEPATITIS B
EA201590931A1 (en) HETEROCYCLIC SUBSTITUTED DERIVATIVES 2-AMINO-HINAZOLINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201790963A1 (en) ANTI-VIRUS COMPOUNDS
EA201391495A1 (en) DERIVATIVES OF PYRIMIDINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201592184A1 (en) 4'-FLUOR-2'-METHYL SUBSTITUTED NUCLEOSIDE DERIVATIVES
EA201500383A1 (en) DERIVATIVES 1,2,4-TRIAZINE FOR THE TREATMENT OF VIRAL INFECTIONS
EA202191622A1 (en) STABILIZED SOLUBLE RSV F-PROTEINS BEFORE FUSION
EA201691216A1 (en) COMPOUNDS OF LINACLOTIDE WITH Slow Release
EA201891378A1 (en) POLYCYCLIC COMPOUNDS AS BRUTTON TYROSINKINASE INHIBITORS
EA201792689A1 (en) DERIVATIVES 2- (PYRAZOLOPIRIDIN-3-IL) Pyrimidine as inhibitors of JAK